Materials & Resources » Chemicals | Skinvisible Inc.

Skinvisible Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
513.40
196.60
-
3.00
23.30
2.50
Total Accounts Receivable
12.70
10.60
6.10
11.10
256.50
9.60
Inventories
22.40
83.20
91.00
79.70
26.00
17.40
Other Current Assets
0.50
-
-
-
10.00
12
Total Current Assets
549.10
290.40
97.10
93.80
315.90
41.50
Net Property, Plant & Equipment
3.60
3.30
1.70
0.70
0.40
0.10
Total Investments and Advances
-
-
-
-
110.00
-
Intangible Assets
321.40
352.40
301.70
245.10
206.00
178.80
Total Assets
874.10
646.10
400.50
339.60
632.20
220.40
ST Debt & Current Portion LT Debt
2,964.80
4,227.90
4,558.10
4,854.10
5,069.80
Accounts Payable
479.60
420.80
529.20
834.00
612.80
Other Current Liabilities
167.00
348.10
539.20
759.80
1,709.20
Total Current Liabilities
3,611.40
4,996.70
5,626.60
6,447.80
7,391.80
Long-Term Debt
-
-
436.00
-
-
Total Liabilities
3,611.40
4,996.70
6,062.60
6,447.80
7,391.80
Common Equity (Total)
2,737.40
4,350.70
5,662.10
6,108.20
6,759.60
Total Shareholders' Equity
2,737.40
4,350.70
5,662.10
6,108.20
6,759.60
Total Equity
2,737.40
4,350.70
5,662.10
6,108.20
6,759.60
Liabilities & Shareholders' Equity
874.10
646.10
400.50
339.60
632.20

About Skinvisible

View Profile
Address
6320 South Sandhill Road
Las Vegas Nevada 89120
United States
Employees -
Website http://www.skinvisible.com
Updated 07/08/2019
company. The company develops a polymer delivery system, Invisicare and formulated skin products through its subsidiary. It develops topical prescription and over-the-counter products enhanced with Invisicare to license to pharmaceutical and consumer goods companies around the world for an upfront fee and ongoing royalties.